| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a St. Joseph Cancer Institute, Towson, University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland
b Thoracic Oncology Program, University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland
c Columbia Presbyterian Medical Center, New York, New York
d Valley Hospital, Ridgewood, New Jersey
e National Institutes of Health, Bethesda, Maryland
Accepted for publication August 27, 2009.
* Address correspondence to Dr Krasna, The Cancer Institute, St. Joseph Medical Center, 7501 Osler Dr, Suite 104, Towson, MD 21204 (Email: markkrasna{at}catholichealth.net).
Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006
Background: We studied the clinical characteristics and outcomes of patients undergoing pneumonectomy after preoperative concurrent chemoradiation for non-small cell lung cancer.
Methods: Clinical records of patients with non-small cell lung cancer who underwent pneumonectomy at our institution between 1995 and 2005 after preoperative concurrent chemoradiation were reviewed retrospectively.
Results: Twenty-nine patients underwent pneumonectomy after preoperative concurrent chemoradiation. Of the 21 men and 8 women who were treated, 1 had stage IIB (T3N0M0) and the remainder had stage IIIA or IIIB non-small cell lung cancer. Mean patient age at surgery was 53.4 years. There were 15 right pneumonectomies, of which 2 were for pancoast tumors. All patients received concurrent preoperative chemoradiation. Mean total radiation dose was 61.1 Gy. All patients went on to have complete (R0) resection by pneumonectomy. Pathologic complete response was found in 16 patients (55.2%). All patients were discharged alive from the hospital after pneumonectomy. Median hospital length of stay was 5 days (mean 8.6). Ninety-day mortality after surgery was 3.4% (n = 1). Recurrences have been found in 11 patients (38%), including brain metastases (n = 6), bone metastases (n = 4), liver metastases (n = 2), and cervical lymph node metastases (n = 2). One patient had a contralateral new primary lung cancer develop 70 months after undergoing pneumonectomy. Estimated 5-year disease-free survival is 48%. Median survival time has not been reached.
Conclusions: Pneumonectomy can be performed safely after preoperative concurrent chemoradiation, even with high-dose radiation. The frequency of disease recurrence in the brain underscores the need to evaluate the role of prophylactic cranial radiation in non-small cell lung cancer.
This article has been cited by other articles:
|
|
 |
|
  A. W. Kim, D. J. Boffa, Z. Wang, and F. C. Detterbeck An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 55 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Kim, M. J. Liptay, P. Bonomi, W. H. Warren, S. Basu, E. C. Farlow, and L. P. Faber Neoadjuvant Chemoradiation for Clinically Advanced Non-Small Cell Lung Cancer: An Analysis of 233 Patients Ann. Thorac. Surg., July 1, 2011; 92(1): 233 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Fernandez, S. D. Force, A. Pickens, P. D. Kilgo, T. Luu, and D. L. Miller Impact of Laterality on Early and Late Survival After Pneumonectomy Ann. Thorac. Surg., July 1, 2011; 92(1): 244 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. T. Daly, M. I. Ebright, A. J. Walkey, H. C. Fernando, K. S. Zaner, D. M. Morelli, and L. A. Kachnic Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1392 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Paul, F. Mirza, J. L. Port, P. C. Lee, B. M. Stiles, A. L. Kansler, and N. K. Altorki Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: Age, mediastinal downstaging, and extent of pulmonary resection as independent predictors J. Thorac. Cardiovasc. Surg., January 1, 2011; 141(1): 48 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krasna Reply to the Editor J. Thorac. Cardiovasc. Surg., March 1, 2010; 139(3): 807 - 807. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
